» Authors » Maximilian Anagnostakis

Maximilian Anagnostakis

Explore the profile of Maximilian Anagnostakis including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 4
Citations 10
Followers 0
Related Specialty
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Fiste O, Mavrothalassitis E, Kokkalis A, Anagnostakis M, Gomatou G, Kontogiannis A, et al.
Clin Transl Oncol . 2024 Dec; PMID: 39668275
Background: Neoadjuvant systemic therapy (NAT) represents an attractive option for improved outcomes of early-stage breast cancer (BC) patients, as it can significantly reduce tumor burden thus permitting breast-conserving resections. Equally...
2.
Kokkotou E, Anagnostakis M, Evangelou G, Syrigos N, Gkiozos I
Cancers (Basel) . 2024 Apr; 16(7). PMID: 38611092
Conventional cancer clinical trials can be time-consuming and expensive, often yielding results with limited applicability to real-world scenarios and presenting challenges for patient participation. Real-world data (RWD) studies offer a...
3.
Evangelou G, Vamvakaris I, Papafili A, Anagnostakis M, Peppa M
Cancers (Basel) . 2024 Mar; 16(6). PMID: 38539512
Lung neuroendocrine tumors (LNETs) and gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are two distinct types of neuroendocrine tumors (NETs) that have traditionally been treated as a single entity despite originating from different...
4.
Trontzas I, Vathiotis I, Economidou C, Petridou I, Gomatou G, Grammoustianou M, et al.
Vaccines (Basel) . 2022 Apr; 10(4). PMID: 35455367
Background: SARS-CoV-2 mortality rates are significantly higher in patients with lung cancer compared with the general population. However, little is known on their immunization status after vaccination. Methods: To evaluate...